Thermo launches AAV production, digital PCR systems

By Melissa Busch, The Science Advisory Board contributing writer

Thermo Fisher Scientific announced that it has launched two new products. The first product is an adeno-associated virus (AAV) production system, while the second is a digital polymerase chain reaction (dPCR) system.

The Gibco AAV-MAX helper-free AAV production system aims to simplify the workflow involved in AAV vector production by delivering high viral titers using Viral Production Cells 2.0, a new, clonally documented, 293F-derived mammalian cell line.

Additionally, the company unveiled the Applied Biosystems QuantStudio Absolute Q digital PCR system, which is designed to provide highly accurate and consistent results within 90 minutes. The system uses microfluidic array technology and simpler workflows, and it was designed to improve the accuracy and consistency of data.

Thermo Fisher Scientific
Applied Biosystems QuantStudio Absolute Q digital PCR system, an integrated digital PCR solution, can be used for oncology, cell and gene therapy development, and other research applications. Image courtesy of Thermo Fisher Scientific.

The dPCR technology powering the QuantStudio Absolute Q platform is used by biotech companies and academic institutions for longitudinal monitoring of cancer-driving mutations in liquid biopsy, precise quantification of gene inserts for cell therapy development, and copy-number variation studies for earlier identification of genetic conditions in newborns, the company said.

Copyright © 2021

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking